Status:
TERMINATED
Fatty Liver in Inflammatory Bowel Disease (IBD) Patients
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Inflammatory Bowel Disease
Fatty Liver
Eligibility:
All Genders
18+ years
Brief Summary
Fatty liver is known to be one of the most frequent liver pathologies in IBD patients (35-40%). Despite this fact, there are only few publications that evaluated the prevalence of fatty liver in IBD p...
Eligibility Criteria
Inclusion
- IBD patients above the age of 18 years old, suffering from the disease for at least one year.
Exclusion
- Pregnant women,
- Patients suffering from ulcerative colitis after total colectomy,
- HIV patients,
- Patients suffering from other chronic liver disease,
- Patients suffering from cancer currently or in the past, OR
- Patients suffering from any other chronic severe diseases.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00855907
Start Date
March 1 2009
End Date
March 1 2011
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv Sourasky Medical center
Tel Aviv, Israel, 64239